Merck & Co Inc (MRK)
131.19
+0.31
(+0.24%)
USD |
NYSE |
May 17, 16:00
131.19
0.00 (0.00%)
Pre-Market: 04:28
Merck Cash from Operations (Annual): 13.01B for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.01B |
| December 31, 2022 | 19.10B |
| December 31, 2021 | 14.11B |
| December 31, 2020 | 10.25B |
| December 31, 2019 | 13.44B |
| December 31, 2018 | 10.92B |
| December 31, 2017 | 6.451B |
| December 31, 2016 | 10.38B |
| December 31, 2015 | 12.54B |
| December 31, 2014 | 7.989B |
| December 31, 2013 | 11.65B |
| December 31, 2012 | 10.02B |
| December 31, 2011 | 12.38B |
| December 31, 2010 | 10.82B |
| December 31, 2009 | 3.392B |
| December 31, 2008 | 6.572B |
| December 31, 2007 | 6.999B |
| December 31, 2006 | 6.765B |
| Date | Value |
|---|---|
| December 31, 2005 | 7.608B |
| December 31, 2004 | 8.799B |
| December 31, 2003 | 9.862B |
| December 31, 2002 | 9.286B |
| December 31, 2001 | 8.343B |
| December 31, 2000 | 7.687B |
| December 31, 1999 | 6.131B |
| December 31, 1998 | 5.328B |
| December 31, 1997 | 6.317B |
| December 31, 1996 | 5.428B |
| December 31, 1995 | 2.944B |
| December 31, 1994 | 4.140B |
| December 31, 1993 | 3.048B |
| December 31, 1992 | 2.504B |
| December 31, 1991 | 2.434B |
| December 31, 1990 | 2.056B |
| December 31, 1989 | 1.381B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
10.25B
Minimum
2020
19.10B
Maximum
2022
13.98B
Average
13.44B
Median
2019
Cash from Operations (Annual) Benchmarks
| Amgen Inc | 8.471B |
| Johnson & Johnson | 22.79B |
| Eli Lilly and Co | 4.240B |
| Pfizer Inc | 8.70B |
| Moderna Inc | -3.118B |